Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The current state of digital cytology and artificial intelligence (AI): global survey results from the American Society of Cytopathology Digital Cytology Task Force.

Journal of the American Society of Cytopathology·2024
Same author

Digital cytology part 1: digital cytology implementation for practice: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force.

Journal of the American Society of Cytopathology·2023
Same author

Digital cytology part 2: artificial intelligence in cytology: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force.

Journal of the American Society of Cytopathology·2023
Same author

The World Health Organization Reporting System for Lung Cytopathology.

Acta cytologica·2022
Same author

Melanotic medullary thyroid carcinoma: A case report with review of the literature.

Diagnostic cytopathology·2022
Same author

A comparative study of the genotype profiles of high-risk human papillomavirus infection in male and female HIV-positive patients and their correlation with anal cytology and biopsy.

Journal of the American Society of Cytopathology·2021

Related Experiment Video

Updated: Feb 28, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Analytic inquiry: Molecular testing in lung cancer.

Maureen F Zakowski1

  • 1Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York.

Cancer Cytopathology
|June 14, 2017
PubMed
Summary

Recent advances in understanding genetic alterations have transformed non-small cell lung cancer (NSCLC) diagnosis and treatment. Cytopathologists must grasp these molecular changes to effectively guide patient care for this deadly disease.

Keywords:
genetic alterationsmolecular subsetsnon-small cell lung canceroncogenic driverstherapeutic targets

More Related Videos

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.8K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K

Related Experiment Videos

Last Updated: Feb 28, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.8K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K

Area of Science:

  • Oncology
  • Molecular Pathology
  • Cytopathology

Background:

  • Non-small cell lung cancer (NSCLC) has evolved significantly due to a decade of progress in understanding its molecular drivers.
  • Key genetic alterations are now recognized as oncogenic drivers and therapeutic targets, defining new molecular subsets of NSCLC.
  • These advancements impact clinical care, patient outcomes, and pathologic diagnosis, posing challenges for cytopathologists.

Purpose of the Study:

  • To review the molecular background of NSCLC and its implications for cytologic and histologic diagnoses.
  • To explain the essential knowledge cytologists need to contribute effectively to NSCLC patient care.
  • To prepare the next generation of cytopathologists for the evolving landscape of lung cancer diagnosis and treatment.

Main Methods:

  • Review of recent scientific literature on NSCLC molecular alterations and targeted therapies.
  • Analysis of the impact of molecular subtyping on diagnostic approaches in cytopathology.
  • Discussion of educational needs for cytopathologists in the context of precision medicine for NSCLC.

Main Results:

  • Understanding key genetic alterations has redefined NSCLC, creating distinct molecular subsets.
  • Cytologic and histologic diagnoses now have direct implications for selecting targeted therapies.
  • A new approach is required for cytopathologists to integrate molecular insights into patient management.

Conclusions:

  • Cytopathologists must understand the complex molecular landscape of NSCLC to meet diagnostic and therapeutic challenges.
  • Effective contribution to NSCLC patient care necessitates integrating molecular pathology findings into cytologic practice.
  • Training future cytopathologists on these molecular aspects is crucial for advancing lung cancer treatment.